Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSMA PET for Monitoring Prostate Cancer After Focal HIFU Treatment
NCT07766122Phase 4Not yet recruiting
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Feb 2027
- Primary completion
- Feb 2029
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in prostate cancer (PCa), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Diagnostic performance of PSMA-PET at 12 months. Planned start Feb 2027; status: not yet recruiting.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07766122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07766122.